Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Breast Neoplasm Female × Fulvestrant × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 15 Neoplasms 3 Neoplasm Metastasis 2 Multiple Endocrine Neoplasia Type 1 1 HR+ Breast Cancer 1 Breast Neoplasm Female 1 Breast Diseases 1 Breast Cancer Organoids 1

Interventions

Patient Reported Outcome Measures 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05140655 2021-12-01

Effectiveness and Safety of Fulvestrant in Postmenopausal Women With Advanced Breast Cancer HR+, HER2-

Dr. Reddy's Laboratories SAS

Breast Neoplasm Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡